163 related articles for article (PubMed ID: 20580355)
1. A predicted S-type pyocin shows a bactericidal activity against clinical Pseudomonas aeruginosa isolates through membrane damage.
Ling H; Saeidi N; Rasouliha BH; Chang MW
FEBS Lett; 2010 Aug; 584(15):3354-8. PubMed ID: 20580355
[TBL] [Abstract][Full Text] [Related]
2. Identification and functional analysis of a bacteriocin, pyocin S6, with ribonuclease activity from a Pseudomonas aeruginosa cystic fibrosis clinical isolate.
Dingemans J; Ghequire MG; Craggs M; De Mot R; Cornelis P
Microbiologyopen; 2016 Jun; 5(3):413-23. PubMed ID: 26860427
[TBL] [Abstract][Full Text] [Related]
3. Pore-forming pyocin S5 utilizes the FptA ferripyochelin receptor to kill Pseudomonas aeruginosa.
Elfarash A; Dingemans J; Ye L; Hassan AA; Craggs M; Reimmann C; Thomas MS; Cornelis P
Microbiology (Reading); 2014 Feb; 160(Pt 2):261-269. PubMed ID: 24217175
[TBL] [Abstract][Full Text] [Related]
4. Comparative study on R-type pyocins of Pseudomonas aeruginosa.
Ohsumi M; Shinomiya T; Kageyama M
J Biochem; 1980 Apr; 87(4):1119-25. PubMed ID: 6771248
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic effects of pyocin S2 produced by Pseudomonas aeruginosa on the growth of three human cell lines.
Abdi-Ali A; Worobec EA; Deezagi A; Malekzadeh F
Can J Microbiol; 2004 May; 50(5):375-81. PubMed ID: 15213746
[TBL] [Abstract][Full Text] [Related]
6. Relationship of resistance phenotype to the R-pyocin susceptibility pattern in clinical isolates of Pseudomonas aeruginosa.
Petrocheilou-Malliara K; Koukoubanis N; Legakis N
Chemioterapia; 1987 Jun; 6(2 Suppl):199. PubMed ID: 3151341
[No Abstract] [Full Text] [Related]
7. [Bactericidal spectrum of pyocins on strains collected at Region IX and X hospitals in Chile].
García-Quintana HG; Polette M; Ríos J
Rev Med Chil; 1989 Jun; 116(6):543-8. PubMed ID: 2501848
[TBL] [Abstract][Full Text] [Related]
8. Discovery, characterization and in vivo activity of pyocin SD2, a protein antibiotic from Pseudomonas aeruginosa.
McCaughey LC; Josts I; Grinter R; White P; Byron O; Tucker NP; Matthews JM; Kleanthous C; Whitchurch CB; Walker D
Biochem J; 2016 Aug; 473(15):2345-58. PubMed ID: 27252387
[TBL] [Abstract][Full Text] [Related]
9. A predicted immunity protein confers resistance to pyocin S5 in a sensitive strain of Pseudomonas aeruginosa.
Rasouliha BH; Ling H; Ho CL; Chang MW
Chembiochem; 2013 Dec; 14(18):2444-6. PubMed ID: 24222552
[No Abstract] [Full Text] [Related]
10. [Antibiotic sensitivity and pyocin dependence of clinical strains of Ps. aeruginosa].
Savitskaia KI; Levina EN
Antibiotiki; 1977 Dec; 22(12):1117-21. PubMed ID: 413475
[TBL] [Abstract][Full Text] [Related]
11. [Phenotypic relations with regard to pyocin sensitivity, of 191 strains of Pseudomonas aeruginosa isolated in a hospital environment].
Santini G; Targa S; Basaglia M; Marchetti G; Crovatto M
Boll Ist Sieroter Milan; 1983 Jul; 62(3):242-6. PubMed ID: 6416270
[TBL] [Abstract][Full Text] [Related]
12. A Colicin M-Type Bacteriocin from Pseudomonas aeruginosa Targeting the HxuC Heme Receptor Requires a Novel Immunity Partner.
Ghequire MGK; Öztürk B
Appl Environ Microbiol; 2018 Sep; 84(18):. PubMed ID: 29980560
[TBL] [Abstract][Full Text] [Related]
13. Assessment of bacteriocin production by clinical Pseudomonas aeruginosa isolates and their potential as therapeutic agents.
Charkhian H; Soleimannezhadbari E; Bodaqlouei A; Lotfollahi L; Lotfi H; Yousefi N; Shojadel E; Gholinejad Z
Microb Cell Fact; 2024 Jun; 23(1):175. PubMed ID: 38872163
[TBL] [Abstract][Full Text] [Related]
14. Alpha-helical domain is essential for antimicrobial activity of high mobility group nucleosomal binding domain 2 (HMGN2).
Feng Y; Huang N; Wu Q; Bao L; Wang BY
Acta Pharmacol Sin; 2005 Sep; 26(9):1087-92. PubMed ID: 16115376
[TBL] [Abstract][Full Text] [Related]
15. Microarray analysis of Pseudomonas aeruginosa reveals induction of pyocin genes in response to hydrogen peroxide.
Chang W; Small DA; Toghrol F; Bentley WE
BMC Genomics; 2005 Sep; 6():115. PubMed ID: 16150148
[TBL] [Abstract][Full Text] [Related]
16. Purification of the pyocin S2 complex from Pseudomonas aeruginosa PAO1: analysis of DNase activity.
Seo Y; Galloway DR
Biochem Biophys Res Commun; 1990 Oct; 172(2):455-61. PubMed ID: 2122894
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic stress induces a large amount of outer membrane protein in Pseudomonas aeruginosa.
Nakajima A; Hoshikawa M; Nakae T
FEMS Microbiol Lett; 1998 Aug; 165(2):261-5. PubMed ID: 9742697
[TBL] [Abstract][Full Text] [Related]
18. Biochemical properties of a new flexuous bacteriocin, pyocin F1, produced by Pseudomonas aeruginosa.
Kuroda K; Kageyama M
J Biochem; 1979 Jan; 85(1):7-19. PubMed ID: 104991
[TBL] [Abstract][Full Text] [Related]
19. The membrane action mechanism of analogs of the antimicrobial peptide Buforin 2.
Hao G; Shi YH; Tang YL; Le GW
Peptides; 2009 Aug; 30(8):1421-7. PubMed ID: 19467281
[TBL] [Abstract][Full Text] [Related]
20. Activity of 4-quinolones against Pseudomonas aeruginosa.
Morissey I; Smith JT
Arzneimittelforschung; 1994 Oct; 44(10):1157-61. PubMed ID: 7818593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
